These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11709461)

  • 1. The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists.
    Padhani AR; Ollivier L
    Br J Radiol; 2001 Nov; 74(887):983-6. PubMed ID: 11709461
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review.
    Kim JH; Kim BJ; Jang HJ; Kim HS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):729-735. PubMed ID: 28780726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QA procedures for multimodality preclinical tumor drug response testing.
    Lee YC; Goins BA; Fullerton GD
    Med Phys; 2010 Sep; 37(9):4806-16. PubMed ID: 20964200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor response evaluation in oncology: current update.
    Shanbhogue AK; Karnad AB; Prasad SR
    J Comput Assist Tomogr; 2010 Jul; 34(4):479-84. PubMed ID: 20657213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can paediatric radiologists resist RECIST (response evaluation criteria in solid tumours)?
    McHugh K; Kao S
    Pediatr Radiol; 2003 Nov; 33(11):739-43. PubMed ID: 14655676
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential pitfalls in computer tomography.
    Angenent JF; Schönfeld DH; Mali WP; van Waes PF
    Diagn Imaging; 1979; 48(6):326-35. PubMed ID: 527458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on criteria for assessing tumor response to treatment.
    Cruite I; Osman S; Dighe M
    Curr Probl Diagn Radiol; 2013; 42(5):209-19. PubMed ID: 24070714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Malignancies Treated With Intra-Arterial Therapy: Assessment of Early Response as Quantified by Volumetric Enhancement Using Gadoxetate Disodium.
    Xu C; Sobhani F; Murano E; Corona-Villalobos C; Pozzessere C; Rastegar N; Kamel IR
    J Comput Assist Tomogr; 2016; 40(2):206-11. PubMed ID: 26720204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET-CT modification of RECIST guidelines.
    O'Connell M
    J Natl Cancer Inst; 2004 May; 96(10):801-2; author reply 802. PubMed ID: 15150309
    [No Abstract]   [Full Text] [Related]  

  • 10. Fast volumetric data acquisition in abdominal computed tomography and magnetic resonance imaging.
    Van Hoe L
    J Belge Radiol; 1997 Oct; 80(5):258. PubMed ID: 9400062
    [No Abstract]   [Full Text] [Related]  

  • 11. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric evaluation of therapy response in patients with lung metastases. Preliminary results with a computer system (CAD) and comparison with unidimensional measurements.
    Fraioli F; Bertoletti L; Napoli A; Calabrese FA; Masciangelo R; Cortesi E; Catalano C; Passariello R
    Radiol Med; 2006 Apr; 111(3):365-75. PubMed ID: 16683084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
    Stacchiotti S; Collini P; Messina A; Morosi C; Barisella M; Bertulli R; Piovesan C; Dileo P; Torri V; Gronchi A; Casali PG
    Radiology; 2009 May; 251(2):447-56. PubMed ID: 19261927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhancement in primary tumors of the brain and spinal cord.
    Castillo M
    Neuroimaging Clin N Am; 1994 Feb; 4(1):63-80. PubMed ID: 8130953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
    Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
    J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different tumor response criteria in patients with hepatocellular carcinoma after systemic therapy with the multikinase inhibitor sorafenib.
    Spira D; Fenchel M; Lauer UM; Claussen CD; Gregor M; Bitzer M; Horger M
    Acad Radiol; 2011 Jan; 18(1):89-96. PubMed ID: 20926315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging beyond RECIST: CT and MRI in molecular therapies.
    Diederich S
    Cancer Imaging; 2012 Sep; 12(2):347-50. PubMed ID: 23023112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Handling the therapeutic response from the tumor with PET].
    Baena Cañada JM
    Rev Esp Med Nucl; 2010; 29(5):273-4. PubMed ID: 20675018
    [No Abstract]   [Full Text] [Related]  

  • 19. [Understanding scans].
    Thiesse P; Carretier J; Vincent C; Digabel-Chabay C; Troufleau P; Brunereau L; Monnier I; Bourguet P
    Bull Cancer; 2004 Apr; 91(4):359-61. PubMed ID: 15242319
    [No Abstract]   [Full Text] [Related]  

  • 20. Measures of response: RECIST, WHO, and new alternatives.
    Jaffe CC
    J Clin Oncol; 2006 Jul; 24(20):3245-51. PubMed ID: 16829648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.